Cardiff Oncology Overview
Cardiff Oncology (CRDF) has a PEG ratio of 18.27, above the Healthcare sector average of 1.26.
Get informed when a big investor buys or sells
+ Follow18.27
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
As of the most recent data, CRDF shows a PEG ratio of 18.27. That is above the Healthcare sector average of 1.26. Scroll down for historical charts and peer comparison views.
The Healthcare sector average PEG ratio is about 1.26. Cardiff Oncology is at 18.27, which is higher that average. That is roughly 1353.3% above the sector mean. Use the comparison chart on this page to see how CRDF stacks up against individual peers as well.
Investors watch CRDF's PEG ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Cardiff Oncology's latest reading is 18.27. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this peg ratio page, Stockcircle has Cardiff Oncology's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PEG ratio (currently 18.27) with ownership activity and broader fundamentals.
The Healthcare average PEG ratio is about 1.26, while CRDF is at 18.27. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
